From bioinformatics to anti-inflammation and immune regulation: ACT001 in lipopolysaccharide-induced lung injury

ACT001 is a potent anti-inflammatory small-molecule drug. However, the single cell and spatial molecular basis of pyroptosis and whether ACT001 exerts a therapeutic effect by preventing pyroptosis on acute lung injury (ALI) remains unclear.